-
$19.99
-
1 mg
Description
Mounjaro® (tirzepatide) is an injectable prescription used primarily to manage type 2 diabetes. Developed by Eli Lilly, it functions uniquely by targeting both GIP and GLP-1 receptors, enhancing insulin release and decreasing glucose output from the liver.